Notice ID: c0fa055913f647c4b3262722fd66122fSpecial NoticeArchived
Pharmacogenomic Analysis of Participants Enrolled in the STAR-B Randomized Clinical Trial of Semaglutide for Alcohol Use Disorder
Archived on September 30, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 3:00 PM EDT
- Posted
- September 8, 2026
- Notice type
- Special Notice
- Set-aside
- No Set aside used
- NAICS
- 541380: Testing Laboratories and Services
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Place of performance
- Baltimore, Maryland
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- NOI-PCA-NIDA-09054
- Notice ID
- c0fa055913f647c4b3262722fd66122f
Description
Please see the attached Notice of Intent titled NOI-PCA-NIDA-09054 and Statement of Work.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
Lifecycle
- 3Version 3Special NoticeArchivedCurrent
Pharmacogenomic Analysis of Participants Enrolled in the STAR-B Randomized Clinical Trial of Semaglutide for Alcohol Use Disorder
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Centers for Disease Control (CDC) is issuing this synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for a California-based integrated health care system to serve as an electronic health record site in CDC’s VISION 2.0 respiratory pathogen surveillance network, providing integrated, longitudinal medical, laboratory, pharmacy, vaccination, claims, and outcomes data to support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research across emergency/urgent care, inpatient, and intensive care unit (ICU) settings. The result of this market research will contribute to determining the method of acquisition. The applicable North American Industry Classification System (NAICS) code assigned to this acquisition is 541380- Testing Laboratories and Services. | 68% | Market Research | 12/04/2026 |
Husbandry Animal Services | 59% | Market Research | 11/09/2026 |
Louisville VAMC seeks a contract for laboratory services to run surface sample testing and personnel aseptic technique competency testing results (gloved fingertip and thumb sampling and media fill testing) for the Pharmacy Service s sterile compounding spaces. **Solicitation closing will be moved to WED 11/04/2026 @ 1500 EST. | 59% | Solicitation | 11/04/2026 |
The South Texas Veterans Health Care System requires contractor services to perform testing and certification of sterile compounding facilities, including primary and secondary engineering controls as described in the attached Performance Work Statement (PWS), at the Audie L. Murphy Memorial VA Hospital Pharmacy Service. All work shall be performed in accordance with applicable standards and the related testing described in the attached PWS. The contractor shall provide all labor, equipment, and documentation needed to fulfill the requirements outlined in the PWS. | 59% | Combined Synopsis | 11/17/2026 |
Louisville VAMC seeks a contract for laboratory services to run surface sample testing and personnel aseptic technique competency testing results (gloved fingertip and thumb sampling and media fill testing) for the Pharmacy Service s sterile compounding spaces. | 59% | Pre-Solicitation | 11/02/2026 |
Additional Details
Solicitation Number
NOI-PCA-NIDA-09054
Archive Date
Sep 30, 2026
Office Address
Bethesda, MD, 20892, US